Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate
Tuesday, January 4, 2011 - 09:30
in Health & Medicine
Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies.